Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A computational approach for the identification of key genes and biological pathways of chronic lung diseases: a systems biology approach. | BMC Med Genomics | 2023 | 37422662 | PubTator, text mining | PubMed |
| Genetic and pharmacological inhibition of GRPR protects against acute kidney injury via attenuating renal inflammation and necroptosis. | Mol Ther | 2023 | 37415332 | PubTator, text mining | PubMed |
| Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. | Autophagy | 2023 | 37408174 | PubTator, text mining | PubMed |
| Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing. | Front Oncol | 2023 | 37404756 | PubTator, text mining | PubMed |
| Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal-fetal interface following SARS-CoV-2 infection. | Nat Cell Biol | 2023 | 37400500 | PubTator, text mining | PubMed |
| Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators. | Front Microbiol | 2023 | 37396372 | PubTator, text mining | PubMed |
| Chemoprevention of lotus leaf ethanolic extract through epigenetic activation of the NRF2-mediated pathway in murine skin JB6 P+ cell neoplastic transformation. | J Tradit Complement Med | 2023 | 37396151 | PubTator, text mining | PubMed |
| NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia. | Cell Death Discov | 2023 | 37391442 | PubTator, text mining | PubMed |
| Genomic analyses in Cornelia de Lange Syndrome and related diagnoses: Novel candidate genes, genotype-phenotype correlations and common mechanisms. | Am J Med Genet A | 2023 | 37377026 | PubTator, text mining | PubMed |
| Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants. | Viruses | 2023 | 37376697 | PubTator, text mining | PubMed |
| Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption. | Nutrients | 2023 | 37375664 | PubTator, text mining | PubMed |
| Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor. | Genes (Basel) | 2023 | 37372475 | PubTator, text mining | PubMed |
| Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. | Biomedicines | 2023 | 37371804 | PubTator, text mining | PubMed |
| The Interplay between Dysregulated Metabolism and Epigenetics in Cancer. | Biomolecules | 2023 | 37371524 | PubTator, text mining | PubMed |
| New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. | Cancer Metastasis Rev | 2023 | 37368179 | PubTator, text mining | PubMed |
| Design, Synthesis, and Biological Evaluation of New Urushiol Derivatives as Potent Class I Histone Deacetylase Inhibitors. | Chembiochem | 2023 | 37366008 | PubTator, text mining | PubMed |
| Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells. | ACS Omega | 2023 | 37360445 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing. | Cancers (Basel) | 2023 | 37345150 | PubTator, text mining | PubMed |
| Potential of Synthetic and Natural Compounds as Novel Histone Deacetylase Inhibitors for the Treatment of Hematological Malignancies. | Cancers (Basel) | 2023 | 37345145 | PubTator, text mining | PubMed |
| Epigenetics: Novel crucial approach for osteogenesis of mesenchymal stem cells. | J Tissue Eng | 2023 | 37342486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=18